Abbott/AstraZeneca Come Together Over Statin/Fibrate Combo
This article was originally published in The Pink Sheet Daily
Executive Summary
Two parallel programs have been initiated in search of the next combination cholesterol management drug.
You may also be interested in...
Abbott, AstraZeneca To Combine Next-Generation Fenofibrate With Crestor In Phase III
The companies are aiming to submit the lipid-regulating combination in 2009.
Abbott, AstraZeneca To Combine Next-Generation Fenofibrate With Crestor In Phase III
The companies are aiming to submit the lipid-regulating combination in 2009.
Sciele/LifeCycle’s “Meltdose” Fenofibrate Clears FDA
Sciele will launch fenofibrate formulation in 40 mg and 120 mg strengths for hyperlipidemia and hypertriglyceridemia by the end of 2007.